Search research articles
Contact Us
Filters
Showing results (1-10 of 223) with videos related to
Page
of 23
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
April 9, 2008
Should we still use glucose-suppressed growth hormone levels for the evaluation of acromegaly?
Annamaria Colao, Gaetano Lombardi
Frontiers in Endocrinology
|
June 2, 2012
Frontiers in cancer endocrinology
Annamaria Colao, Gaetano Lombardi
European Journal of Endocrinology
|
March 13, 2002
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly
Annamaria Colao, Paolo Marzullo, Gaetano Lombardi
JAMA
|
April 8, 2004
Screening and treatment for subclinical thyroid disease
Bernadette Biondi, Gaetano Lombardi, Emiliano A Palmieri
Fertility and Sterility
|
June 15, 2004
Does raloxifene inhibit the growth of uterine fibroids?
Stefano Palomba, Fulvio Zullo, Francesco Orio, et al.
Endocrine Reviews
|
February 11, 2004
Systemic complications of acromegaly: epidemiology, pathogenesis, and management
Annamaria Colao, Diego Ferone, Paolo Marzullo, et al.
Endocrinology and Metabolism Clinics of North America
|
April 27, 2005
The metabolic syndrome and cardiovascular risk in Cushing's syndrome
Rosario Pivonello, Antongiulio Faggiano, Gaetano Lombardi, et al.
Biologics : Targets & Therapy
|
August 27, 2009
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
Bernadette Biondi, Melania Pulcrano, Loredana Pagano, et al.
Clinical Endocrinology
|
June 20, 2002
(99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy
Annamaria Colao, Diego Ferone, Gaetano Lombardi, et al.
Treatments in Endocrinology
|
August 28, 2004
Cardiac abnormalities in acromegaly. Pathophysiology and implications for management
Giovanni Vitale, Rosario Pivonello, Gaetano Lombardi, et al.
Page
of 23
Search research articles
Search
Showing results (1-10 of 223) with videos related to
Sort By:
Page
of 23
The Journal of Clinical Endocrinology and Metabolism
|
April 9, 2008
Should we still use glucose-suppressed growth hormone levels for the evaluation of acromegaly?
Annamaria Colao, Gaetano Lombardi
Frontiers in Endocrinology
|
June 2, 2012
Frontiers in cancer endocrinology
Annamaria Colao, Gaetano Lombardi
European Journal of Endocrinology
|
March 13, 2002
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly
Annamaria Colao, Paolo Marzullo, Gaetano Lombardi
JAMA
|
April 8, 2004
Screening and treatment for subclinical thyroid disease
Bernadette Biondi, Gaetano Lombardi, Emiliano A Palmieri
Fertility and Sterility
|
June 15, 2004
Does raloxifene inhibit the growth of uterine fibroids?
Stefano Palomba, Fulvio Zullo, Francesco Orio, et al.
Endocrine Reviews
|
February 11, 2004
Systemic complications of acromegaly: epidemiology, pathogenesis, and management
Annamaria Colao, Diego Ferone, Paolo Marzullo, et al.
Endocrinology and Metabolism Clinics of North America
|
April 27, 2005
The metabolic syndrome and cardiovascular risk in Cushing's syndrome
Rosario Pivonello, Antongiulio Faggiano, Gaetano Lombardi, et al.
Biologics : Targets & Therapy
|
August 27, 2009
Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer
Bernadette Biondi, Melania Pulcrano, Loredana Pagano, et al.
Clinical Endocrinology
|
June 20, 2002
(99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy
Annamaria Colao, Diego Ferone, Gaetano Lombardi, et al.
Treatments in Endocrinology
|
August 28, 2004
Cardiac abnormalities in acromegaly. Pathophysiology and implications for management
Giovanni Vitale, Rosario Pivonello, Gaetano Lombardi, et al.
Page
of 23